F/M Investments’s 89bio ETNB Stock Holding History

F/M Investments’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-217,742	Closed	-$2.14M	–	422
2025 Q2	$2.14M	Buy	217,742 +2,905	+1%	+$24.1K	0.08%	232
2025 Q1	$1.56M	Buy	+214,837	New	+$1.88M	0.06%	258

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

F/M Investments's ETNB Position: Q3 2025 in Review

F/M Investments sold out of 89bio (ETNB) in Q3 2025, closing a stake of 217,742 shares — an estimated $2.14M sold.

F/M Investments first reported a position in ETNB in Q1 2025 and held it in 2 quarters. The position peaked at $2.14M in Q2 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

F/M Investments reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
F/M Investments sold 217,742 89bio shares in Q3 2025, an estimated $2.14M.
F/M Investments first reported a position in 89bio in Q1 2025 and held it in 2 quarters.
F/M Investments's 89bio position peaked at $2.14M in Q2 2025.
198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on F/M Investments's 13F filing for Q3 2025, filed 13 Nov 2025.